A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)

Kang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M. -j.; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I.; Ahn, H. K.; Jeung, H. -c.; Lee, S. I.; Oh, S. Y.; Bae, W. K.; Ryu, H.; Park, K. H.; Lee, K. H.

doi:10.1016/j.esmoop.2025.104302

상세 보기

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)

Kang, E. J.;
Yang, Y.;
Lee, S.;
Kim, Y. J.;
Lim, S. M.;
... Choi, Y. J.;
외 12명

Citations

WEB OF SCIENCE

0

Citations

SCOPUS

0

초록

The authors regret that in the original publication Fig. 1A was given incorrectly. The full and correct Fig. 1 is now given below.[Figure presented] The authors would like to apologise for any inconvenience caused. © 2025 Elsevier B.V., All rights reserved.

키워드

Erratum; Female; Human; Male; Multicenter Study; Phase 2 Clinical Trial; Clinical Article

제목: A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)

저자: Kang, E. J.; Yang, Y.; Lee, S.; Kim, Y. J.; Lim, S. M.; Ahn, M. -j.; Choi, Y. J.; Lee, Y.; Kim, T. M.; Kim, I.; Ahn, H. K.; Jeung, H. -c.; Lee, S. I.; Oh, S. Y.; Bae, W. K.; Ryu, H.; Park, K. H.; Lee, K. H.

DOI: 10.1016/j.esmoop.2025.104302

발행일: 2025-04

유형: Correction

저널명: ESMO Open

권: 10

호: 4